🇺🇸 FDA
Patent

US 6133240

Tetrahydronapthalene derivatives and their therapeutic use

expired A61KA61K31/704A61P

Quick answer

US patent 6133240 (Tetrahydronapthalene derivatives and their therapeutic use) held by Darwin Discovery Limited expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Darwin Discovery Limited
Grant date
Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/704, A61P, A61P1/00, A61P11/02